logo
Can Chiropractors Effectively Treat Sciatica Pain?

Can Chiropractors Effectively Treat Sciatica Pain?

Health Line02-07-2025
Chiropractic care is a popular natural treatment for sciatica. It can relieve pain without medication and is generally considered a safe treatment option.
Sciatica is a common condition that affects between 10% and 40% of people. Most cases of mild sciatica resolve on their own. However, when sciatica doesn't resolve on its own, it can lead to chronic pain and muscle weakness.
Medical treatment options generally include:
lifestyle adjustments
pain medications
physical therapy
surgery, in severe cases
Some people with sciatica seek treatment outside traditional medical care.
Learn more about what research shows about chiropractic care for sciatica, as well as other tips to cope with sciatic pain.
What is sciatica?
Sciatica is a pain that's triggered when your sciatic nerve becomes injured or inflamed.
Your sciatic nerve travels from your lower back, past your hips, and down each leg. Sciatica pain can be found anywhere along this path and is often felt through the entire length.
Most people only experience sciatica on one side of their body. The pain can range from mild to severe. The pain can be felt as an electric shock or as a deep aching pain. It can also cause your affected leg and foot to feel numb or weak.
This most common cause of sciatica is a herniated disk in your spine that presses on the sciatic nerve. It can also occur when a bone spur presses on the nerve or when your spine is narrowed and puts pressure on the nerve.
Sciatica often resolves on its own within several weeks. When it doesn't, it's a good idea to see a medical professional.
Left untreated, some cases of sciatica can lead to permanent damage to your sciatica nerve. This could cause you to lose feeling in your affected leg or even lose control of your bowel and bladder.
What are the basics of chiropractic care?
Chiropractic care centers on spinal manipulation and other manual therapies to help relieve pain and treat conditions. Spinal manipulation involves applying controlled force to the spine or joints to alleviate pain.
In the United States, all chiropractors are required earn a Doctor of Chiropractic degree before they can practice. They also need to earn a license in the state where they work.
Chiropractic care is considered a holistic healthcare method. This means that it focuses on care for your whole body and not just the specific area of your pain.
A chiropractor will ask you about your pain as well as your health history at your first appointment. This helps them develop a specialized treatment plan for you.
You might also have X-rays taken, so the chiropractor can understand what's causing your pain. For example, an X-ray might show that your spine is narrowed and pinching your sciatic nerve.
Treatment involves stretching and applying controlled pressure to your joints. The chiropractor might recommend specific exercises for you to do at home to help with your pain. Some may also provide nutrition and wellness education that can help relieve your symptoms.
You'll generally need to see a chiropractor multiple times before you begin to get relief from sciatica.
Does research support the use of chiropractic for sciatica?
People sometimes seek chiropractic care for sciatica and other painful conditions. This is because chiropractic care may be a more appealing option for long-term pain management than taking medication every day.
You also may have already tried numerous traditional solutions to pain management, such as medication and physical therapy, without finding relief.
Chiropractic care is often easy to find. You don't need a medical referral to see a chiropractor, and many of these practices can see you very quickly. Plus, chiropractic care is increasingly covered by health insurance plans.
However, chiropractic care remains controversial.
Until recent years, no studies demonstrated that chiropractic care was safe or effective. A few studies looked into the effectiveness of chiropractic care for sciatica, but these have important limitations. Studies have only been done using small sample sizes, and even then, results varied.
According to a 2025 study, people with sciatica who received chiropractic spinal manipulation instead of opioids had fewer side effects one year after treatment start compared to a control group that received standard treatment of medications. Researchers said that starting chiropractic care sooner led to the decreased needs of using opioid medications later.
According to a 2021 review of available research, spine manipulation therapy was deemed to sometimes—but not always—be effective for some forms of nerve pain, though not specifically sciatica. It's sometimes offered as a frontline treatment, sometimes alongside exercise or physical therapy, and sometimes alongside medications.
What are other natural ways to help with sciatica?
If you're not sure about chiropractic care but want to treat your sciatic naturally, you have options. You can help ease your sciatica pain at home in several ways.
Some suggestions for natural relief include:
Take breaks during your workday: Sitting in the same position for long hours can aggravate sciatica. Try taking a break and changing sitting positions throughout your day. You may find you're in less pain by the end of the day.
Build back strength: You can do low impact exercises, such as bridges. Strengthening these muscles will improve spinal support, which can reduce your sciatica symptoms. To avoid the risk of making your pain worse, take it slow and do these exercises carefully.
Stretch your hip and hamstring muscles: Tight muscles in your hips and hamstrings put pressure on your lower back. Stretching these muscles helps many people see significant improvement in their sciatica pain.
Use ice packs: Ice packs can help relieve the pain of sciatica. You can use an ice pack for up to 20 minutes at a time.
Try heat: Hot packs, heating pads, or even warm water in the shower may help reduce your pain.
Take up yoga: Yoga can help improve your strength, posture, and flexibility, and also provide pain relief. Plus, you'll get the great benefits of exercise and relaxation that come with yoga.
Get a massage: A massage can loosen tight muscles and provide significant pain relief.
Consider acupuncture: For some people, acupuncture can be an effective method of controlling pain.
Ask a doctor about physical therapy: This includes a combination of exercise, education, and manual therapy.
When to get medical treatment
Mild cases of sciatica often resolve on their own. When the pain doesn't resolve quickly, it's a good idea to seek out medical care. Contact a medical professional if your sciatica pain:
has lasted more than a week
gets worse every day
doesn't get better with over-the-counter medications or rest
causes your leg to feel weak or numb
causes you to experience incontinence
Bottom line
A chiropractor might be able to help relieve sciatica pain. Using spinal manipulation techniques and other natural practices, chiropractors can help relieve the pressure on your sciatic nerve.
There is limited evidence to support chiropractic for sciatica, but many people report finding relief after visiting a chiropractor. Chiropractic care is generally considered safe, and there are very few risks to trying this treatment method.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

Yahoo

time42 minutes ago

  • Yahoo

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

Yahoo

time42 minutes ago

  • Yahoo

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

UnitedHealth's Profits Fall as Costs of Care Continue to Rise
UnitedHealth's Profits Fall as Costs of Care Continue to Rise

New York Times

time44 minutes ago

  • New York Times

UnitedHealth's Profits Fall as Costs of Care Continue to Rise

UnitedHealth Group, the giant health care conglomerate, said on Tuesday that it continued to struggle with higher-than-anticipated costs of providing medical care to patients enrolled in its health plans, reporting a drop in earnings for the quarter ended June 30. While UnitedHealth remained profitable, its operating earnings for the three months fell to $5.2 billion from $7.9 billion in the same period of 2024. Revenues, however, increased to $111.6 billion for the three months of 2025, compared with $98.9 billion for the same period of 2024. The higher costs were felt across the company's vast health insurance operations, including one of its most successful businesses, selling private Medicare plans as an alternative to traditional Medicare. UnitedHealth owns the nation's largest health insurer, UnitedHealthcare, which covers 50 million people. Other insurance companies have also reported rising medical costs and disappointing profits. Last Friday, Centene, a for-profit insurance company that focuses mostly on patients who are enrolled in Medicaid and Obamacare plans, was the latest insurer to blame rising expenses for poor financial results. But UnitedHealth's stumble, which began earlier this year, has shocked many of its investors who have come to rely on steady increases of profits from the conglomerate. Since November, the company's stock has lost roughly half of its value. The company owns an assortment of health care businesses, including surgery centers, a vast network of medical practices, and a big pharmacy benefit manager as well as health insurance plans. In the new earnings report, UnitedHealth acknowledged that many of the businesses housed under its Optum unit were also underperforming, including its network of physicians and other clinicians who provide care under the privatized portion of the Medicare program, known as Medicare Advantage. UnitedHealth has experienced a series of misfortunes over the last two years, including the murder of the chief executive of its insurance operations, Brian Thompson. Investors have lost confidence in the company's business model, and patients have grown increasingly frustrated with its methods. In May, it abruptly replaced its chief executive, Andrew Witty, with Stephen Hemsley, who had stepped down from the position in 2017. Last week, the company confirmed the Department of Justice was investigating its Medicare operations. UnitedHealth announced its earnings before the stock market opened. Mr. Hemsley took steps to reassure investors. The company, which had withdrawn its profit outlook for the year, provided investors with an estimate of what it expected to earn for 2025. It estimated revenues of slightly under $450 billion with net earnings of at least $14.65 per share. The company said it expected to return to earnings growth in 2026. 'UnitedHealth Group has embarked on a rigorous path back to being a high-performing company fully serving the health needs of individuals and society broadly,' Mr. Hemsley said in a statement in the company's earnings release. 'As we strengthen operating disciplines, positioning us for growth in 2026 and beyond, the people at UnitedHealth Group will continue to support the millions of patients, physicians and customers who rely on us, guided by a culture of service and longstanding values.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store